Category: Clinical Trial
Clinical Trial market research reports by Roots Analysis
-
Blockchain in Drug Discovery and Clinical Trials Market, 2023-2035
Blockchain in Drug Discovery and Clinical Trials Market, 2023-2035 Blockchain technology, also referred to as distributed ledger technology (DLT), serves an integral part of the pharmaceutical supply chain. It enhances the trackability and traceability of drugs and other pharmaceutical products, the ... Read More
-
Digital Twins Market, 2022-2035
Digital Twins Market, 2022-2035 The research and development behind a new drug is reported to require, on an average, an investment of nearly USD 1 billion. At present, over 90% of the drug candidates fail across different stages of clinical trials, leading to significant financial losses for develo ... Read More
-
Global TCR-based Therapy Market (2nd Edition), 2022-2035
Global TCR-based Therapy Market (2nd Edition), 2022-2035 Modified T-cell receptor (TCR)-based therapy is an emerging class of adoptive therapy that employs genetically modified lymphocytes to target specific tumor markers. Their tumor-cell killing efficacy may be primarily attributed to the fact th ... Read More
-
Clinical Trial Patient Recruitment Services Market (3rd Edition), 2022-2035
Clinical Trial Patient Recruitment Services Market (3rd Edition), 2022-2035 INTRODUCTION Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. As these trials are prone to delays, and can even ... Read More
-
DNA Encoded Library: Platform and Services Market (2nd Edition), 2023-2035
DNA Encoded Library: Platform and Services Market (2nd Edition), 2023-2035 DNA Encoded Library Market Overview The global DNA encoded library market is estimated to be worth USD 840 million in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 16.04% during the forecast period 2 ... Read More
-
Intranasal Therapeutics and Drug Delivery Systems Market, 2022-2035
Intranasal Therapeutics and Drug Delivery Systems Market, 2022-2035 Over the past few years, the prevalence of neurological disorders has increased at an annualized rate of 10.9%. Further, the mortality associated with such diseases is projected to account for 12.2% of the global death rate, in 203 ... Read More
-
Site Management Organizations Market, 2021-2035
Site Management Organizations Market, 2021-2035 INTRODUCTION Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. Studies suggest that around 40% of the total investment made for the developme ... Read More
-
AI in Clinical Trials Market (2nd Edition): AI Software and Service Providers, 2023-2035
AI in Clinical Trials Market (2nd Edition): AI Software and Service Providers, 2023-2035 1.1. AI IN CLINICAL TRIALS OVERVIEW The global AI in clinical trials market is estimated to be worth $ 1.4 billion in 2023 and expected to grow at compounded annual growth rate (CAGR) of 16% during the forecast ... Read More
-
Site Management Organizations Market by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phase (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035
Site Management Organizations Market by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phase (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Ot ... Read More
-
Antiviral Drugs Market, 2022-2035
Antiviral Drugs Market, 2022-2035 Infectious diseases are known to be one of the top 10 leading causes of deaths, worldwide. In-fact, more than 40 million people are affected by various types of infectious diseases annually. An article published in The Lancet journal reported that COVID-19 alone ca ... Read More
-
Viral Clearance and Testing Services Market, 2023-2035
Viral Clearance and Testing Services Market, 2023-2035 INTRODUCTION Viral clearance and testing refers to the detection and elimination of viral contaminants, using a wide array of methods, to ensure the product’s safety for human use. Over the past few years, viral clearance and testing has emerged ... Read More
-
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035 Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. As these trials are prone to delays, and can even fail altogethe ... Read More
-
Rare Kidney Disorders Market, 2022-2035
Rare Kidney Disorders Market, 2022-2035 The term rare kidney diseases represents around 150 different indications. It is worth highlighting that the prevalence rate of rare kidney disorders (RKD) is estimated to be 60-80 per 100,000 cases / individuals in the US and Europe. Despite their relatively ... Read More
-
NAMPT Inhibitors Market, 2022-2040
NAMPT Inhibitors Market, 2022-2040 Globally, cancer is one of the leading causes of death; in 2020, about 10 million cancer related deaths were reported. Further, according to a study published in American Cancer Society Journal, by 2040, the number of cancer cases is projected to reach over 28 mil ... Read More
-
Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)
Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for No ... Read More
-
Clinical Trials Software Market, 2022-2035: Distribution by Type of Deployment (on-cloud, on-premises), Type of Delivery (web-based, remote monitoring), Features of software (EDC, eCOA/ePRO, eConsent) and Geographical Regions (North America, Europe and Asia-Pacific)
Clinical Trials Software Market, 2022-2035: Distribution by Type of Deployment (on-cloud, on-premises), Type of Delivery (web-based, remote monitoring), Features of software (EDC, eCOA/ePRO, eConsent) and Geographical Regions (North America, Europe and Asia-Pacific) 1. It is a well-known fact that c ... Read More
Research Assistance
